Vanda starts trial of NEREUS drug for GLP-1 side effects
Go back to Vanda starts trial of NEREUS drug for GLP-1 side effects| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 5.99 +0.19 (3.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.80 | 52 Week High | $18.00 | |||
| Open | $5.86 | 52 Week Low | $6.91 | |||
| Day High | $6.03 | P/E | N/A | |||
| Day Low | $5.83 | EPS | $-0.67 | |||
| Volume | 441,957 | |||||
